Integrating Chronic Disease Management and Harm Reduction for Youth with Juvenile Idiopathic Arthritis Amid Canada’s Overdose Crisis
2024

Managing Chronic Pain and Substance Use Risks in Youth with Arthritis

Commentary

Author Information

Author(s): Adebiyi Babatope O., Birnie Kathryn A., Schmeling Heinrike

Primary Institution: University of Calgary

Hypothesis

Can integrating chronic disease management with harm reduction strategies improve outcomes for youth with juvenile idiopathic arthritis amid Canada's overdose crisis?

Conclusion

An integrated approach combining chronic disease management and harm reduction can help protect youth with juvenile idiopathic arthritis from opioid dependency and improve their quality of life.

Supporting Evidence

  • Juvenile idiopathic arthritis is a common chronic condition in children that requires long-term pain management.
  • The opioid crisis in Canada has led to increased risks for youth with chronic conditions like JIA.
  • Integrated care models can help manage chronic pain while reducing the risk of substance use disorders.

Takeaway

This study suggests that kids with arthritis who need pain medicine should also get help to avoid problems with drugs. By working together, doctors can make sure they feel better and stay safe.

Limitations

The commentary does not provide specific data or empirical evidence to support its recommendations.

Participant Demographics

Youth with juvenile idiopathic arthritis in Canada.

Digital Object Identifier (DOI)

10.3390/children11121424

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication